Sakai, H., Morise, M., Kato, T., Matsumoto, S., Sakamoto, T., Kumagai, T., . . . Paik, P. K. (2021). Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study. Jpn J Clin Oncol.
Citação norma ChicagoSakai, Hiroshi, et al. "Tepotinib in Patients With NSCLC Harbouring MET Exon 14 Skipping: Japanese Subset Analysis From the Phase II VISION Study." Jpn J Clin Oncol 2021.
Citação norma MLASakai, Hiroshi, et al. "Tepotinib in Patients With NSCLC Harbouring MET Exon 14 Skipping: Japanese Subset Analysis From the Phase II VISION Study." Jpn J Clin Oncol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.